Activity report - Elysisa - Sept. 2015
1
page
English
Documents
2015
Le téléchargement nécessite un accès à la bibliothèque YouScribe Tout savoir sur nos offres
1
page
English
Documents
2015
Le téléchargement nécessite un accès à la bibliothèque YouScribe Tout savoir sur nos offres
Dear investors, I am pleased to send you the latest Elysisa ac7vity report! A new website has been launched and the cubicle is completed.
Voir
Dear investors, I am pleased to send you the latest Elysisa ac7vity report! A new website has been launched and the cubicle is completed. A collabora7on agreement is signed with IBA and the company started sales. A capital increase is planned in Q3 2015 to feed growth.
Business Model
•
•
••
Concept: integrated solution for dedicated quality control laboratories for the production of radio‐pharmaceuticals Sales and marketing: sales through cyclotron producers (e.g. IBA) Delivery model: idem as sales Revenue model:product sales and maintenance fees
Achievements (Q1 – Q2 2015)
Collaboration agreement signed with IBA Launch of the new website Cubicle completed Elysia joins Rad4med, the Belgian Network for Radiation applications in Healthcare
Main objectives (2015)
••••••
Finalisation of product and offer design Hire team Increase R&D to be less dependent of suppliers Commercial launch end of May (website and lyers) Participation of EANM 2015 in October First prototype of their own equipment (detector and layer chromatography) for October
QuarterlyReport‐–JDuenc3301,20154
COUNTRY
SECTOR
INVESTMENT
56,250€
Health
TEAM
ENTREPRENEUR(S)
F. Moonen CEO
D. Bartholemy CTO ‐ Sales
STAGE
Seed
OWNERSHIP
9,9%
EMPLOYEE(S) 7
KEY PERFORMANCE INDICATORS
Published on septembre 3, 2015
N.a.: investment made on 28/4/2014
SHAREHOLDERS
1
